TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial).

Hitomi S Okuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.